| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 37,430 | 43,578 | 55,021 | 36,499 |
| Marketable securities and other investments | 21,607 | 24,739 | 22,234 | 51,801 |
| Trade and other receivables, net of allowance for credit losses of 79 and 112, respectively | 17,880 | 8,786 | 12,201 | 14,962 |
| Prepaid expenses and other current assets | 16,183 | 15,121 | 20,105 | 17,128 |
| Current assets held for sale from discontinued operations | 0 | 5,640 | 6,427 | 6,440 |
| Total current assets | 93,100 | 97,864 | 115,988 | 126,830 |
| Property and equipment, net | 22,624 | 22,997 | 22,978 | 21,179 |
| Operating lease right-of-use assets | 1,271 | 1,394 | 1,573 | 1,780 |
| Intangible assets, net | NaN | NaN | 69 | 73 |
| Deferred contract costs | 3,382 | 3,425 | 3,136 | 3,399 |
| Other non-current assets | 40,882 | 41,425 | 42,559 | 25,938 |
| Non-current assets held for sale from discontinued operations | 0 | 2,940 | 3,263 | 3,873 |
| Total assets | 161,259 | 170,045 | 189,566 | 183,072 |
| Accounts payable | 259 | 1,826 | 772 | NaN |
| Deferred revenue | 34,022 | 19,385 | 25,325 | NaN |
| Accrued compensation | 3,988 | 4,555 | 4,596 | NaN |
| Other current liabilities | 13,181 | 8,872 | 9,235 | NaN |
| Current liabilities held for sale from discontinued operations | 0 | 4,816 | 5,744 | NaN |
| Total current liabilities | 51,450 | 39,454 | 45,672 | NaN |
| Non-current liabilities held for sale from discontinued operations | NaN | 154 | 160 | NaN |
| Other non-current liabilities | 1,496 | 1,415 | 1,420 | NaN |
| Total liabilities | 52,946 | 41,023 | 47,252 | NaN |
| Redeemable noncontrolling interest - held for sale from discontinued operations | NaN | 0 | 0 | NaN |
| Series a redeemable convertible preferred stock, par value 0.00001 per share 200,000 shares authorized as of march31, 2026 and december31, 2025, 150 shares issued and outstanding as of march31, 2026 and december31, 2025, respectively (note 8) | 164,226 | 159,495 | 154,799 | NaN |
| Series a redeemable convertible preferred stock, par value 0.00001 per share 200,000 shares authorized as of december 31, 2025 and 2024, 150 shares issued and outstanding as of december 31, 2025 and 2024, respectively (note 9) | NaN | 159,495 | 154,799 | NaN |
| Class a, class b and class c common stock, par value 0.00001 per share 3,000,000 (class a 1,800,000, class b 600,000, class c 600,000) shares authorized as of march31, 2026 and december31, 2025 247335631 (class a 244,080, class b 3,256, class c 0) and 256043436 (class a 252787051, class b 3,256, class c 0) shares issued and outstanding as of march31, 2026 and december31, 2025, respectively | 2 | 2 | 2 | NaN |
| Additional paid-in capital | 1,343,247 | 1,360,704 | 1,375,276 | NaN |
| Accumulated other comprehensive income | 663 | 597 | 555 | NaN |
| Accumulated deficit | -1,399,825 | -1,391,776 | -1,388,318 | NaN |
| Total stockholders equity | -55,913 | -30,473 | -12,485 | NaN |
| Total liabilities, redeemable equity and stockholders equity | 161,259 | 170,045 | 189,566 | 183,072 |
Blend Labs, Inc. (BLND)
Blend Labs, Inc. (BLND)